NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE145557 Query DataSets for GSE145557
Status Public on Jan 27, 2021
Title A novel neural stem cell-derived immunocompetent mouse model of glioblastoma for preclinical studies (RNA-Seq)
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Glioblastomas are the most lethal tumors affecting the central nervous system in adults. Simple and inexpensive syngeneic in vivo models that closely mirror human glioblastoma, including interactions between tumor and immune cells, are urgently needed for deciphering glioma biology and developing more effective treatments. Here, we generated mouse glioblastoma cell lines by repeated in-vivo passaging of neural stem cells and tumor tissue of a neural stem cell-specific Pten/p53 double-knockout genetic mouse model. Transcriptome and genome analyses of the cell lines revealed molecular heterogeneity comparable to that observed in human glioblastoma. Upon orthotopic transplantation into syngeneic hosts they formed high-grade gliomas that faithfully recapitulated the histopathological characteristics, invasiveness and infiltration by myeloid cells characteristic of human glioblastoma. These features make our cell lines unique and useful tools to study multiple aspects of glioma pathomechanism and test immunotherapies in syngeneic preclinical models.
 
Overall design Mouse glioblastoma cell lines were established using a genetically engineered, Tamoxifen-induced Pten/Tp53 double knockout specific to neural stem cells. The first passages of each line were establised by in vitro, stem-cell maintaining culture of cells either isolated from the sub-ventricular zone 2 weeks after induction (tNSC0) or from gross tumour (mGB0). Each line was serially transplanted (following intervening further in vitro expansion) into recipient mice to establish the mGB (mGB0, mGB1, mGB2) and tNSC (tNSC0, tNSC1, tNSC2, tNSC3) lines. Normal neural stem cells (experimental control for all mGB and tNSC samples) and splenocytes (copy number-normal control) were also isolated. in vitro-cultured cells were then analysed using whole exome sequencing (WES) and RNA-seq.
 
Contributor(s) Costa B, Fletcher MN, Löwer M, Radlwimmer B, Angel P, Peterziel H
Citation(s) 33435218
Submission date Feb 19, 2020
Last update date Feb 01, 2021
Contact name Bernhard Radlwimmer
E-mail(s) b.radlwimmer@dkfz-heidelberg.de
Organization name Deutsches Krebsforschungszentrum / German National Cancer Research Centre
Department Department of Molecular Genetics
Street address Im Neuenheimer Feld 280
City Heidelberg
ZIP/Postal code 69120
Country Germany
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (8)
GSM4321475 mGB0 RNA-Seq
GSM4321476 mGB1 RNA-Seq
GSM4321477 mGB2 RNA-Seq
This SubSeries is part of SuperSeries:
GSE145559 A novel neural stem cell-derived immunocompetent mouse model of glioblastoma for preclinical studies
Relations
BioProject PRJNA607547
SRA SRP250023

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE145557_GB_GEMMs_Idh1-Idh2_hotspots_SNV_calling_RNAseq.vcf.gz 2.3 Kb (ftp)(http) VCF
GSE145557_GB_GEMMs_mGB_tNSC_log-cpm_expression_Gencode_M2.csv.gz 1.6 Mb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap